Clinical Trial Update: Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating Iparomlimab and Tuvonralimab in combination with concurrent chemoradiation for locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: LOCALLY ADVANCED CERVICAL CANCERS | Phase 2 | Status: RECRUITING